Strategic Growth Certara Evidence & Access combines Analytica Laser and BaseCase to offer end-to-end analytics and value communication for therapies, signaling a strong opportunity to upsell integrated value assessment, real-world evidence, and payer-focused communication services to pharma clients seeking comprehensive market access solutions.

AI and Data Publicized focus on artificial intelligence initiatives and AI-driven growth engines suggests upsell potential for advanced analytics, predictive modeling, and AI-powered real-world evidence generation services to optimize trial design, label claims, and payer negotiations.

Executive Stability Recent leadership transition with interim CFO indicates a moment for deploying trusted strategic initiatives and financial planning services, offering targeted proposals around cost optimization, forecasting, and value-based contracting support for clients amid organizational change.

New Pharma Wins Contract with Gilead Sciences to generate high-quality RWE for remdesivir demonstrates demand for real-world evidence and outcomes-focused narratives, presenting cross-sell opportunities to expand RWE programs across additional therapeutic areas and corporate partnerships.

Global Reach With 14 US offices and 20 international sites and a multinational client base, there is a clear opportunity to pursue multinational market access projects, local country-specific health technology assessments, and global implementation of value communication platforms for global pharma footprints.